top of page
Briefing paper on Value Based Pricing and Cancer Drugs Fund
On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an...

Our Chair, Allyson Kaye, has been awarded an MBE in the New Years Honours List 2014 for services to
Allyson founded Ovarian Cancer Action in 2004, as a campaigning voice for women with ovarian cancer - lobbying for greater understanding...
Media coverage of rare and less common cancers
Rare and less common cancers are going up the media agenda - in June 2013 there was a massive piece in the Telegraph on neuro endocrine...
BBC Scotland programme "Life, Death and Enormous Amounts of Money"
Cancer52 supported the CML Support Group's call for an apology from BBC Scotland for footage within its programme "Life, Death and...
Position statement on Value Based Pricing
On 13th November 2012, Cancer52 published its Position Statement on Value Based Pricing.


QiC Excellence in Oncology Awards
Simon Davies, Chair of Cancer52, presented Professor Sir Mike Richards CBE with his Lifetime Achievement Award at the QiC Oncology Awards...
Cancer52 Annual Review 2012
Cancer 52's Annual Review 2012 summarises the growth of the organisation and highlights of its activities. Please click here to download...


Second Annual Briefing at House of Lords - October 2012
Nearly 80 people attended Cancer52’s second annual briefing at the House of Lords on Thursday 18th October. Attendees included a mix of...
Cancer52 Second Annual Briefing - House of Lords
The full report on the Cancer52 Second Annual Briefing held on 18th October at the House of Lords is now available here.
Cancer52 Second Annual Briefing Report
In October 2012, Cancer52 held its second annual briefing at the House of Lords. You can read the report here.
bottom of page